Biopharma Operations evolved to deliver the highest service level in respect of large and relatively stable production volumes by investing in inventory and production capacity – fulfilment whatever the cost!
Today, because there are new drugs targeting narrow indications, smaller volumes are produced. The result of this expanding portfolio of products, combined with outsourcing and globalization, is major complexity in pharmaceutical supply chains.
No surprise, therefore, that Operations now underperforms as a result of this new scenario
More and more supply chain agility is challenged by demand growth in emerging markets. The pressure to cut costs is high, as new generic players are entering the market after the patent protection has expired for a large number of drugs.
By managing these issues effectively, Operations can regain its excellence and become a competitive advantage for those biopharmaceutical companies which recognise the need to act now!
We believe that the right consulting partner must have a deep understanding of what the above challenges mean in the biopharmaceutical environment and have clear methodologies and experience on how to overcome them, and EFESO has these capabilities.
EFESO’s Pharma offer covers the entire value chain, seamlessly incorporating Human Dynamics and Digital transformation. We help our clients to tackle today’s challenges by co-creating a tailored approach which will achieve the best results.
DELIVERING TANGIBLE RESULTS